Corpus Intelligence IC Memo — MINIDOKA MEMORIAL HOSPITAL 2026-04-26 05:28 UTC
IC Memo — MINIDOKA MEMORIAL HOSPITAL
Investment Committee Memorandum | ID | 23 beds | Grade C | EBITDA uplift $3.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MINIDOKA MEMORIAL HOSPITAL

CCN 131319 | MINIDOKA, ID | 23 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MINIDOKA MEMORIAL HOSPITAL is a 23-bed rural/critical access in MINIDOKA, ID with $48.0M in net patient revenue and a -1.3% operating margin. The hospital serves a payer mix of 56.1% Medicare, 8.3% Medicaid, and 35.5% commercial.

Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.3% to 6.0% (+736bps).

Net Revenue HCRIS$48.0M
Current EBITDA COMPUTED$-646K
Operating Margin COMPUTED-1.3%
Occupancy HCRIS25.6%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS58.4%
Distress Probability ML57.6%

2. Market Context & Competitive Position

51
ID Hospitals
-3.5%
State Median Margin
31
Comparable Hospitals

ID has 51 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of -1.3% places it above the state median. Among 31 size-comparable peers (12-46 beds), the median margin is -3.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 31 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MINIDOKA MEMORIAL HOSPITAL (Target)ID23$48.0M-1.3%
MOUNTAIN VIEW HOSPITALID43$382.5M8.7%
BINGHAM MEMORIAL HOSPITALID25$164.8M-3.6%
NORTHWEST SPECIALTY HOSPITALID32$120.3M3.7%
TREASURE VALLEY HOSPITALID28$114.8M36.1%
ST. LUKES WOOD RIVER MEDICAL CID25$99.1M13.5%
GRITMAN MEDICAL CENTERID25$92.4M-6.4%
BONNER GENERAL HOSPITALID25$61.2M-7.6%
NORTH CANYON MEDICAL CENTERID16$53.7M4.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$960K+200bp12mo
Denial Rate Reduction12.0%6.5%$950K+198bp12mo
A/R Days Reduction5200.0%3800.0%$584K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$960K
Denial Rate Reduction
$950K
A/R Days Reduction
$584K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.5M
Current EBITDA$-646K
+ RCM Uplift+$3.5M
Pro Forma EBITDA$2.9M
Current Margin-1.3%
Pro Forma Margin6.0%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-995K$31.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-995K$33.8M0.00x-100.0%
Bull Case9.0x11.0x$-895K$45.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-895K$49.0M0.00x-100.0%
Bear Case11.0x10.0x$-1.1M$13.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.1M$14.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 56.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 25.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 31 hospitals with 12-46 beds
  • Same-state prioritization (n=32)
  • Comp margins: P25=-8.9% / P50=-3.3% / P75=2.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.